Feedback Activation of EGFR/Wild-Type RAS Signaling Axis Limits KRAS^G12D Inhibitor Efficacy in KRAS^G12D-Mutated Colorectal Cancer

Scientists reported that MRTX1133 treatment caused reversible growth arrest in KRASG12D-mutated colorectal cancer cells, accompanied by partial reactivation of RAS effector signaling.